US Tariffs Impact on Swiss SMEs: How to Protect Your Business in 2026
Quick Answer
US 10% flat tariff impact on Swiss exports 2026: GDP forecast cut to 0.8%, watch industry at risk, 8 protection strategies. Data-driven guide for Swiss SMEs with US market exposure.
Last updated: April 2026
Global trade has been turned upside down for Swiss businesses. Since February 2026, a flat 10% additional tariff on Swiss goods shipped into the United States has redrawn the competitive map for thousands of SMEs across the country. Whether your firm is based in Zurich's financial quarter, in Basel's pharmaceutical corridor, or in one of the precision engineering clusters spread across the Mittelland, understanding this tariff regime and responding with a clear plan is no longer a nice-to-have. For many businesses, it is a condition of survival.
This guide gives Swiss SME leaders – CEOs, CFOs, and managing directors – the data, context, and concrete strategies they need to operate confidently in the US tariff environment throughout 2026 and beyond.
What Are the Current US Tariffs on Swiss Goods?
Swiss goods entering the United States have faced a flat 10% additional tariff since February 24, 2026. A bilateral agreement between Switzerland and the US caps that rate at a maximum of 15%, a significant improvement over the 39% rate that was in force before the November 2025 deal.
The path to the current situation was steep. In the final months of 2025, Swiss exporters were staring down a 39% tariff rate that threatened to hollow out entire sectors. After months of pressure and negotiation, Switzerland and the US reached an agreement in November 2025 that brought the rate down substantially. From February 24, 2026, a flat 10% additional tariff applies to Swiss goods, with the bilateral deal setting 15% as the ceiling (Reuters, 2026).
The situation is not fully settled, however. If the United States moves to impose sectoral levies – particularly targeting pharmaceuticals – a specific 15% tariff could apply to pharma exports alone. That matters enormously because pharmaceuticals account for nearly half of all Swiss goods shipped to the US market (Swiss Federal Council, 2026).
The numbers are easy to illustrate with a concrete case. A Zurich-based medical device manufacturer exporting CHF 5 million of goods to the US each year now faces CHF 500,000 in additional tariff costs. For businesses running on thin margins, that figure alone can tip a profitable year into a loss.
How Are US Tariffs Affecting the Swiss Economy?
GDP growth forecasts have been sharply revised downward, export-dependent sectors are contracting, and the persistently strong Swiss franc is adding a second layer of pressure on every company selling into the American market.
GDP Growth Forecasts Cut Sharply
The macroeconomic signal is already clear. EY Switzerland has lowered its Swiss GDP growth forecast to 0.6% for 2026, compared with the roughly 1.5% that analysts expected before the tariff escalation (EY Switzerland Economic Outlook, 2026). The State Secretariat for Economic Affairs (SECO) offers a slightly more optimistic view at 1.1% growth, but even that figure represents a meaningful step back from earlier projections (SECO Economic Forecast, Spring 2026).
Switzerland grew at approximately 1.5% in 2025. A drop to anywhere between 0.6% and 1.1% will ripple through hiring plans, supplier relationships, and capital investment decisions – from Geneva's trading firms to St. Gallen's textile producers.
The Strong Swiss Franc: A Double Blow
The tariff burden arrives alongside a currency problem. The Swiss franc remains historically strong against both the euro and the US dollar. With the Swiss National Bank (SNB) holding its policy rate at 0% and Swiss inflation running at only 0.3-0.5%, the interest rate differential continues to pull capital into CHF (Swiss National Bank, 2026). For Swiss exporters, that combination is damaging: on top of the 10% tariff, their goods land in the US at a higher dollar price simply because of the exchange rate. No pricing tweak alone can bridge that gap.
Which Swiss Sectors Are Most Affected by US Tariffs?
Pharmaceuticals, watches, machinery, precision instruments, and chemicals carry the greatest exposure. Pharma alone represents nearly half of the total export impact.
Pharmaceuticals
The pharmaceutical sector, anchored in Basel but supported by hundreds of SME suppliers and contract manufacturers spread across Switzerland, accounts for close to 50% of Swiss goods exported to the United States. If the proposed 15% sectoral tariff on pharmaceuticals is enacted, the effect will travel through the entire supply chain – from active pharmaceutical ingredient producers in the Espace Mittelland to logistics operators in Schaffhausen.
Watches and Luxury Goods
Swiss watchmakers face the 10% additional tariff on every piece that crosses into the US. The industry spans major brands in the Jura Arc down to smaller workshops in Biel/Bienne and La Chaux-de-Fonds. For luxury pieces, a 10% cost increase may be manageable. For entry-level Swiss Made watches where margins are already tight, it fundamentally changes the pricing equation in the American market.
Machinery and Precision Engineering
Swiss mechanical and electrical engineering exports fell sharply in Q4 2025 as the tariff threat became real. Companies in Winterthur, Schaffhausen, and the greater Zurich area that supply CNC machines, automation equipment, and precision components to US manufacturers are watching their cost advantage over domestic US suppliers shrink in real time.
Chemicals and Precision Instruments
Specialty chemicals producers and precision instrument manufacturers – many of them SMEs based in the Bern and Lucerne regions – face parallel exposure. These sectors frequently operate under long-term supply contracts that include no tariff adjustment clauses. That leaves companies absorbing costs they never planned for when the contracts were signed.
8 Strategies for Swiss SMEs to Navigate US Tariffs
The right response is not a single lever but a combination of pricing analysis, market diversification, supply chain review, financial hedging, and legal contract updates. Here is what each of those looks like in practice.
1. Review Your Pricing Strategy
Every Swiss SME exporting to the US must make a core decision: absorb the tariff cost, pass it through to the customer, or negotiate a split. There is no universal right answer. A Lucerne-based precision parts manufacturer with unique capabilities and no direct substitute may be able to recover most of the 10% tariff cost through higher prices. A Zurich machinery company competing against German and Japanese alternatives may have to absorb more to hold its market position.
Model three scenarios for each significant US customer account: full absorption, full pass-through, and a 50/50 split. Calculate what each does to margin and identify the point at which the relationship is no longer worth keeping. That analysis should be completed within 30 days if it has not started already.
2. Diversify Export Markets
Reducing dependence on the US market is a strategic priority, not just a contingency. The EU remains Switzerland's largest trading partner, and the recent progress on the bilateral framework agreement is stabilising market access conditions. Asian markets – Japan, South Korea, and Southeast Asia in particular – offer growth for Swiss quality goods. A St. Gallen textile machinery company, for instance, may find that Southeast Asian manufacturers are actively looking for exactly the Swiss precision equipment that American buyers are now resisting on price.
3. Review Your Supply Chain for US-Based Production
For SMEs with substantial US revenues, local production or assembly may justify the investment. Swiss companies as a group have committed to USD 200 billion in US investment over five years, with USD 67 billion planned for 2026 alone (SWI swissinfo.ch, 2026). That commitment is led by large corporations, but it signals a broader direction: serving the US market from within the US may be the most durable tariff mitigation available to Swiss SMEs with annual US revenues above CHF 2-3 million.
4. Implement FX Hedging Strategies
Unhedged export revenues in USD represent meaningful risk when the franc is this strong. Swiss SMEs should work with their bank – UBS, the successor entities to Credit Suisse, or a cantonal bank – to put forward contracts or options in place covering 6-12 months of expected USD receipts. A CHF/USD forward contract at current rates removes exchange rate volatility from the tariff impact calculation, which makes strategic decision-making considerably cleaner.
5. Update Financial Forecasts with Tariff Scenarios
Your 2026 budget and financial forecast needs tariff-adjusted scenarios built into it. At minimum, model three outcomes: the current 10% tariff holding through year-end, a reduction to 5% if negotiations progress, and an escalation to 15% if sectoral levies are imposed. Each scenario should flow through to cash flow, headcount plans, and capital investment decisions. This is precisely where an experienced outsourced CFO adds measurable value – especially for SMEs that do not have a senior finance function in-house.
6. Review Contracts for Tariff-Related Clauses
Go through every US-facing contract and look for price adjustment mechanisms, force majeure provisions, and any language that touches tariffs. Many contracts signed before 2025 contain none of that. Work with legal counsel to renegotiate where possible, adding clauses that tie permissible price adjustments to documented tariff changes. For new contracts, include that mechanism as a baseline term.
7. Consider a US Entity or Subsidiary
For Swiss SMEs generating US revenues above CHF 5 million annually, a US subsidiary – whether structured as an LLC or a C-Corp – can allow component imports at lower tariff rates, with final assembly or value-add work performed on US soil. That approach requires careful analysis of transfer pricing rules, US corporate tax obligations, and the operational overhead involved. For businesses that qualify, however, the tariff savings can be substantial. Cities such as Austin, Raleigh-Durham, and Nashville have become common landing points for European SMEs establishing US operations.
8. Apply for Available Tariff Exemptions
Certain product categories qualify for tariff exclusions. The US Trade Representative runs periodic exclusion processes for specific goods, and those windows are worth monitoring actively. A US customs broker with experience in the Swiss-US trade relationship is the right partner for this. Industry associations – Swissmem for machinery and electrical engineering, scienceindustries for chemicals and pharmaceuticals – track current exemption opportunities and publish guidance for members.
What Swiss SMEs Should Do Right Now: A 90-Day Action Plan
Immediate priorities are tariff impact quantification, customer communication, contract review, and early-stage planning for market diversification and potential US operations.
Days 1-30: Quantify and Communicate
- Calculate the exact tariff cost on each US product line and customer relationship
- Model pricing scenarios: absorb, pass through, and split
- Communicate proactively with US customers about pricing implications
- Review all US-facing contracts for price adjustment mechanisms
Days 31-60: Hedge and Forecast
- Put CHF/USD hedging in place for the next 6-12 months
- Build tariff-adjusted financial forecasts across three scenarios
- Identify tariff exemption opportunities for your specific product categories
- Begin exploring alternative export markets in the EU and Asia
Days 61-90: Restructure and Invest
- Evaluate the feasibility of US-based production or assembly for your key product lines
- Renegotiate contracts to include tariff adjustment language
- Submit applications for any relevant tariff exclusions
- Develop a 12-month strategic plan that explicitly accounts for tariff uncertainty
How Scalemetrics Helps Swiss SMEs Navigate Tariff Challenges
The Scalemetrics team works with Swiss SMEs across sectors to build financial resilience in uncertain trade environments. Our outsourced CFO services include tariff impact modelling, scenario-based financial forecasting, FX risk management strategy, and strategic advisory on market diversification and US market entry. Whether you are a Basel pharma supplier, a Zurich machinery exporter, or a Biel/Bienne watchmaker, our team converts tariff uncertainty into a structured, data-driven action plan.
Ready to quantify your tariff exposure and build a resilient strategy? Contact Scalemetrics today for a complimentary tariff impact assessment.
Related Resources
Scalemetrics helps Swiss SMEs act on decisions like this before market conditions shift. Our SME financing services and outsourced CFO team give finance directors the senior expertise to move first.
What is the current US tariff rate on Swiss goods in 2026?
Since February 24, 2026, Swiss goods entering the United States face a flat 10% additional tariff. A bilateral deal between Switzerland and the US caps the maximum rate at 15%. This is significantly lower than the 39% tariff that was in effect before the November 2025 agreement. Certain sectors like pharmaceuticals may face the full 15% if sectoral levies are imposed.
How do US tariffs affect Swiss pharmaceutical exports?
Pharmaceuticals account for nearly half of all Swiss exports to the United States, making this sector disproportionately affected. The current 10% tariff adds significant costs, and a proposed 15% sectoral levy on pharma would further increase the burden. Basel-region pharma companies and their SME supply chain partners should model both scenarios in their financial forecasts.
Can Swiss SMEs get exemptions from US tariffs?
Yes, certain product categories may qualify for tariff exclusions through the US Trade Representative's periodic exclusion processes. Swiss SMEs should work with a US customs broker and monitor industry association updates from organisations like Swissmem and scienceindustries. The exclusion process typically requires demonstrating that no adequate domestic US alternative exists for the specific product.
Should Swiss SMEs establish US subsidiaries to avoid tariffs?
Establishing a US entity (LLC or C-Corp) can be an effective tariff mitigation strategy for Swiss SMEs with annual US revenues exceeding CHF 5 million. By importing components and performing assembly or value-add operations locally in the US, companies can reduce the tariff-applicable value. However, this requires careful analysis of transfer pricing, US tax obligations, and operational costs. An outsourced CFO can help model whether this approach makes financial sense for your specific situation.
What is the economic impact of US tariffs on Switzerland's GDP?
US tariffs have significantly impacted Swiss economic growth projections. EY Switzerland has cut its 2026 GDP forecast to 0.6%, down from the pre-tariff expectation of approximately 1.5%. SECO projects a slightly more optimistic 1.1%. The strong Swiss franc (with SNB rates at 0% and inflation at 0.3-0.5%) compounds the challenge for exporters who face both tariff costs and unfavourable currency dynamics when selling to the US market.
Sources & References
US Tariffs and Swiss SMEs: Quantifying the Exposure
The United States remains the largest single-country export market for Swiss goods, absorbing approximately CHF 16–18 billion in Swiss exports annually. The categories most exposed to US tariff policy — watches and precision instruments, pharmaceuticals and biotech products, machinery and industrial equipment, and specialty chemicals — are precisely the sectors where Swiss SMEs are most concentrated. Even a 10–15% blanket tariff increase on Swiss goods entering the US market would represent a material margin erosion for businesses that have built their US pricing on tariff-free assumptions.
The complexity for Swiss SMEs is that US tariff policy in 2025–2026 has been characterised by rapid changes, temporary exemptions, and sector-specific carve-outs that make static modelling inadequate. A company that secured a US tariff exemption in Q3 2025 may find that exemption not renewed in Q1 2026; a competitor that moved production to a third country to avoid tariffs may find that workaround challenged under rules of origin reviews. The only robust approach is dynamic scenario modelling rather than a single-point tariff assumption.
Practical Mitigation Strategies for Swiss Exporters
Pricing power assessment. The first question to answer is whether your US customers would absorb a tariff-driven price increase or whether you would need to absorb it in margin. This depends on how differentiated your product is, how many credible substitutes exist, and how price-sensitive your US customer segment is. Swiss precision engineering and pharmaceutical products typically have high switching costs and limited substitutes — pricing power is relatively strong. Commodity-adjacent goods (industrial components, standardised machinery) face more substitution risk and thus more limited ability to pass tariffs through.
Currency hedging alongside tariff modelling. US tariff shocks and USD/CHF movements often occur simultaneously, compounding or partially offsetting each other. A well-structured CFO analysis models both variables jointly rather than treating them as independent risks. If a 15% tariff increase coincides with a 10% CHF/USD appreciation, the combined margin impact on a USD-invoiced Swiss exporter is approximately 23–25% — potentially company-threatening without mitigation.
Supply chain restructuring options. For Swiss SMEs with high US revenue concentration, three restructuring approaches are being actively evaluated: establishing a light-touch US assembly or finishing operation that shifts the tariff classification of the product; routing through a preferential-tariff third country (Israel, South Korea, and Canada have US trade agreements that may benefit Swiss-origin inputs incorporated into finished goods); or shifting to US-sourced components to reduce the dutiable value of the final product.
US Tariff Scenario Analysis: Swiss SME Impact Matrix
| Tariff Scenario | EBIT Impact (15% US rev. share) | EBIT Impact (40% US rev. share) | Recommended Response |
|---|---|---|---|
| +5% tariff (partial pass-through) | −0.5% EBIT pts | −1.5% EBIT pts | Monitor; review pricing annually |
| +15% tariff (50% pass-through) | −1.1% EBIT pts | −3.0% EBIT pts | Hedge FX; review supply chain |
| +25% tariff (no pass-through) | −3.75% EBIT pts | −10.0% EBIT pts | Structural review required |
Swiss SMEs with significant US revenue exposure cannot afford to treat tariff risk as a low-probability event in 2026. Building a dynamic tariff scenario model, establishing FX hedges for US dollar exposure, and reviewing supply chain structures are all CFO-level activities that require dedicated attention. A strategic CFO engagement can deliver this analysis and the implementation roadmap to protect your US market margins in whatever tariff environment materialises.
